Nephros Inc logo

Nephros Inc

$ 0.97 +0.043 (+4.64%) 10:08 PM EST
P/E:
At Loss
P/B:
1.09
Market Cap:
$ 10.01M
Enterprise V:
$ 6.26M
Volume:
4.67K
Avg Vol (2M):
72.96K
Volume:
4.67K
Market Cap $:
10.01M
PE Ratio:
At Loss
Avg Vol (2-Month):
72.96K
Enterprise Value $:
6.26M
PB Ratio:
1.09
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Nephros Inc is a commercial-stage company that develops and sells high performance water solutions to the medical and commercial markets. In medical markets, it sell water filtration products and waterborne pathogen detection products. In commercial markets, the company manufacture and sell water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The operating segments of the group are Water Filtration, Pathogen Detection and Renal Products of which key revenue is derived from Water Filtration segment.
Name Current Vs Industry Vs History
Cash-To-Debt 4.77
Equity-to-Asset 0.62
Debt-to-Equity 0.1
Debt-to-EBITDA -0.18
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.42
Distress
Grey
Safe
Beneish M-Score -2.2
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 46.33
9-Day RSI 32.62
14-Day RSI 29.01
6-1 Month Momentum % -70
12-1 Month Momentum % -84.38

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.27
Quick Ratio 3.06
Cash Ratio 1.98
Days Inventory 334.77
Days Sales Outstanding 55.76
Days Payable 75.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.6

Financials (Next Earnings Date:2022-11-04 Est.)

NEPH's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NEPH

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.473
EPS (TTM) ($) -0.55
Beta 1.15
Volatility % 52.99
14-Day RSI 29.01
14-Day ATR ($) 0.083462
20-Day SMA ($) 1.081445
12-1 Month Momentum % -84.38
52-Week Range ($) 0.9051 - 8.5
Shares Outstanding (Mil) 10.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nephros Inc Filings

Document Form Filing Date
No Filing Data

Nephros Inc Analysis

Share your research

Headlines

See More
No news.